JUPITER NEUROSCIENCES, INC. Assets Designated to Closed Block, Equity Securities, at Fair Value
JUPITER NEUROSCIENCES, INC. (JUNS) had Assets Designated to Closed Block, Equity Securities, at Fair Value of $35.00 million as of 2026-02-26, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Financial Services
us-gaap:AssetsDesignatedToClosedBlockEquitySecuritiesAtFairValue · last filed 2026-08-14
- 2026-02-26: Assets Designated to Closed Block, Equity Securities, at Fair Value $35.00M.
| Period end | Assets Designated to Closed Block, Equity Securities, at Fair Value |
|---|---|
| 2026-02-26 | $35.00M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |